How many studies have been conducted on Bifidobacterium Breve?

BiohacksAI has indexed 262 PubMed studies on Bifidobacterium Breve, including 40 randomized controlled trials (RCTs). 29% of studies involve human subjects.

What are the main research areas for Bifidobacterium Breve?

The primary research domains for Bifidobacterium Breve are 🦠 Gut & Microbiome, 🔬 Inflammation, 🛡️ Immunity. This is based on analysis of 262 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Bifidobacterium Breve

A species of Bifidobacterium present in the human GUT MICROBIOTA. It is used as a PROBIOTIC.

262+ PubMed studies analyzed · 40 RCTs · Evidence Score: 49.5

Research Domains

Bifidobacterium Breve has been studied across 19 research domains including 🦠 Gut & Microbiome, 🔬 Inflammation, 🛡️ Immunity, 😴 Sleep, 🧠 Neuroprotection. The primary research focus is 🦠 Gut & Microbiome with 87% of studies addressing this area.

Loading evidence profile...

This evidence profile for Bifidobacterium Breve is generated deterministically from 262 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.